Navigation Links
Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering
Date:4/3/2009

letter" that does not constitute an approval or rejection, then the warrants expire on the earlier of the date that is 15 months after the date that the company publicly announces that the FDA issued its complete response letter and the date that is nine months after the date on which the company publicly announces that it has addressed all items required by the FDA before the BLA can be approved.

The closing of the offering is expected to take place on or about April 8, 2009, subject to customary closing conditions. Lazard Capital Markets LLC served as the sole placement agent in connection with the offering. Copies of the final prospectus relating to this offering may be obtained at the Securities and Exchange Commission web site at http://www.sec.gov, or from Savient Pharmaceuticals, Inc. at One Tower Center, 14th Floor, East Brunswick, NJ 08816 Attention: Investor Relations.

The common stock and warrants described above are being offered by Savient pursuant to a registration statement previously filed and declared effective by the Securities and Exchange Commission.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities of the company, nor will there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Savient

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and marketing pharmaceutical products that target unmet medical needs in both niche and broader specialty markets. Savient's product development candidate, KRYSTEXXA(TM) (pegloticase) for treatment-failure gout, has reported positive Phase 1, 2 and 3 c
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2008 Results Conference Call on Thursday, February 26, 2009
2. Savient Announces Appointment of David Gionco as Chief Financial Officer
3. Savient Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference on November 18th
4. Savient Pharmaceuticals Reports Third Quarter 2008 Financial Results
5. Savient Submits Biologics License Application (BLA) for pegloticase
6. Savients Pegloticase Data in Treatment-Failure Gout Patients Presented at 72nd Annual Meeting of the American College of Rheumatology Conference
7. Savient Pharmaceuticals to Hold Third Quarter 2008 Financial Results Conference Call on Thursday, November 6, 2008
8. Amylin Pharmaceuticals Provides Shareholders with Update Regarding Recent Developments
9. Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
10. NovaBay Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
11. Alseres Pharmaceuticals, Inc. Complies with NASDAQ Rule Regarding Recently Filed 10-K
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 29, 2014) – The severe flooding that devastated a ... less destructive if the bridges, roads and other infrastructure ... study from the University of Colorado Denver. , "People ... said Jimmy Kim, PhD, associate professor of structural engineering ... Science and lead author the study. "There is an ...
(Date:10/27/2014)... The Italian company Roadrunnerfoot ... sell its artificial "lower limb", after the German ...      (Photo: http://photos.prnewswire.com/prnh/20141027/713097 ) , ... definitive judgement has arrived: Roadrunnerfoot, the small Italian ... hi-tech prostheses with composite materials, has won against ...
(Date:10/27/2014)... The “Molecular Diagnostic Market by Application (Infectious ... Sequencing), End User (Hospital, Laboratories), & by Product ... 2018” provides a detailed overview of the major ... strategies impacting the global molecular diagnostics market along ... and share analysis. , The global molecular diagnostics ...
(Date:10/27/2014)... The report “Smart Highway Market by ... Monitoring), and by Display (Variable Message Signs, Digital ... global market into various sub-segments with in-depth analysis ... drivers and restraints for this market with insights ... market tables and 37 figures spread through 141 ...
Breaking Biology Technology:CU Denver study says upgrading infrastructure could reduce flood damage 2Italian Lower Limb Prosthesis Company Wins Lawsuit Against German Giant Ottobock 2Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 2Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 3Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 4Global Molecular Diagnostics Market Will Reach $7.9 Billion by 2018 - New Research Report by MarketsandMarkets 5Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 2Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 3Smart Highway Market by Technology, and Display Expected to Reach $27.992.0 Million by 2019- New Report by MarketsandMarkets 4
... 21 ChemDiv Inc. and Avineuro,Pharmaceuticals Inc. ... and development,collaboration including formulation, safety and early ... psychiatric disorders. R&D services,will be provided by ... in Moscow. The new agreement provides for ...
... Queen,s University Belfast is to become the United Kingdom,s ... ,cyber-attacks, after a funding boost from the Engineering and ... the EPSRC will help fund a new Innovation and ... (CSIT) - which will be based at Queen,s Institute ...
... Nov. 20 Par Pharmaceutical Companies, Inc. (NYSE: ... Court for the District of New Jersey last night ... (TRO) halting sales of Teva,s generic Pulmicort Respules(R) (budesonide ... against Teva, AstraZeneca agreed and that it too would ...
Cached Biology Technology:ChemDiv and Avineuro Extend Collaboration on Alzheimer's Disease and Schizophrenia 2Queen's 'secures' £25m for UK's cyber-safety 2Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension 2
(Date:10/29/2014)... Genomics of the Kidney consortium ( CAGEKID ) ... exposure to aristolochic acid, an ingredient in some ... Communications , have important implications for public health. ... every year, and in Central Europe incidence rates ... International Cancer Genome Consortium (ICGC), has been studying ...
(Date:10/28/2014)... German . , ... food when times are lean? By studying wild chimpanzees ... of the Max Planck Institute for Evolutionary Anthropology in ... apes can acquire extra energy needed to maintain large, ... nests more en route to breakfast sites containing fruits ...
(Date:10/28/2014)... National University of Singapore (NUS) have discovered a new ... laying direct developing eggs in live bamboo with narrow ... bush frog ( Raorchestes chalazodes ). This critically ... known to adopt this novel reproductive strategy. The findings ... Biological Journal of the Linnean Society , in October ...
Breaking Biology News(10 mins):Kidney cancer in Central Europe 2The early chimp gets the fig 2The early chimp gets the fig 3NUS researchers discover for the first time that a rare bush frog breeds in bamboo 2NUS researchers discover for the first time that a rare bush frog breeds in bamboo 3
... rise and more than 120 countries now in favor ... create a new, specialized global environmental agency, says one ... address to government ministers meeting Tuesday in Kenya, Zakri ... Malaysia and former co-chair of the UN Millennium Ecosystem ...
... Forum 2012 (ESOF 2012) was officially launched today at the ... Dublin this year from 11th to 15th July. ESOF 2012, ... in the heart of the Irish capital, in the new ... meeting, held under the auspices of Euroscience, which aims to ...
... winner-take-all competition in nature is an essential pillar of ... have about how, or whether, to teach the subject. ... and religion are in deliberate opposition, like two lionesses ... practicing Catholic Kenneth Miller teaches evolution, he also teaches ...
Cached Biology News:Create effective new global environmental agency, ministers urged 2Create effective new global environmental agency, ministers urged 3Science Program announced for Euroscience Open Forum 2012 in Dublin 2Science Program announced for Euroscience Open Forum 2012 in Dublin 3Science Program announced for Euroscience Open Forum 2012 in Dublin 4Science Program announced for Euroscience Open Forum 2012 in Dublin 5Teaching science to the religious? Focus on how theories develop 2Teaching science to the religious? Focus on how theories develop 3